CEFOXITIN

Generic: CEFOXITIN, CEFOXITIN SODIUM

WG Critical CareManufacturer
INTRAVENOUSRoute
CEFOXITIN SODIUMActive Substance
2009-06-12Original Approval

CEFOXITIN is FDA application ANDA065414, sponsored by ACS DOBFAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
97 reports
2
DRUG RESISTANCE
92 reports
3
RASH
81 reports
4
NAUSEA
80 reports
5
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
79 reports
6
DRUG INEFFECTIVE
64 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
64 reports
8
THROMBOCYTOPENIA
62 reports
9
CONDITION AGGRAVATED
57 reports
10
DYSPNOEA
52 reports